Member Article

Knutsford-based Crawford Healthcare agrees new financing deal with HSBC

Knutsford-based Crawford Healthcare, a wound care company, has agreed a major new financing deal with HSBC.

The new funding will help Crawford Healthcare expand into international markets including a launch into Germany and the US.

Since 2009 the company has grown its team to over 100 employees across a number of countries and locations.

In that time, it has developed its own in-house manufacturing and R&D facilities from its bases in Knutsford and Tarvin.

The company is also working with the research team at the University of Manchester to develop a number of anti infective products that will counter the growing global issue of antibiotic resistance, along with other innovations to meet the growing needs of clinicians dealing with chronic wounds.

CEO of Crawford Healthcare, Richard Anderson, said: “Crawford Healthcare is the fastest growing privately held company in this sector, and we have an aggressive but realistic growth strategy in place to ensure we reach £100m turnover in the next three years.

“Alongside our UK model, we’re putting the processes in place to ensure our rapid growth is sustainable, and we see Germany and the US as the key areas in which to do this.

“The new funding arrangement with HSBC will play a major role in facilitating our expansion and we look forward to continuing this partnership in the future.”

HSBC Regional Director of Corporate Banking for the North, David Beaty, said: “HSBC is keen to support ambitious and growing businesses such as Crawford Healthcare, who were ranked the 12th fastest growing company in last year’s Business Insider Growth 100.

“I am pleased we have been able to assist with their exciting growth plans both in the UK and abroad.”

This was posted in Bdaily's Members' News section by Sophia Taha .